Executive promotion signals strategic growth and continued expansion of state-of-the-art 503A and 503B compounding operationsORLANDO, Fla., May 19, 2026 (GLOBE NEWSWIRE) -- Olympia and Wesley ...

They come in blister packs of 10 like any normal painkiller and you can buy them easily in roadside kiosks and street ...

In early May 2026, Niagen Bioscience, Inc. reported first-quarter net sales of US$31.47 million and net income of US$6.32 ...

Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announced a new partnership with Olympia ...

Javascript is required for you to be able to read premium content. Please enable it in your browser settings.

Last month, Tony Lyons, the ally of the health secretary who runs the MAHA PAC, said he’d raise $100 million to support Republicans, bolstering President Donald Trump’s view that MAHA voters will help ...

Despite CBS renewing the series for Matlock Season 3, it's the end of the line for Kathy Bates' leading Madeline "Matty" Matlock character.

Skye P. Marshall, Jason Ritter and Leah Lewis preview tonight's two-hour 'Matlock' finale and explain why 'everything is going to be different' moving forward.

Early results from the OLYMPIA-3 trial reveal odronextamab plus CHOP chemotherapy shows promising efficacy for untreated DLBCL patients, without rituximab. Matthew Matasar, MD, Rutgers Cancer ...

Judith Hey-Hadavi and Nicole Snow discuss staying current on GLP-1 research and managing therapy side effects to support patient outcomes. In this episode, Judith Hey-Hadavi, vice president of Medical ...

In the second episode of our GLP-1 Therapy Insights series, experts Judith Hey-Hadavi from Worldwide Clinical Trials and Nicole Snow from Olympia Pharmaceuticals discuss the evolution of GLP-1 ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min With the launch of a new sister ...